Abstract: Introduction. The future burden of cancer deaths will be the effect of demography changes and the influence of the risk factors. Goal.
Introduction
Estimating current cancer mortality rates is important for defining priorities for prevention, management and treatment. Predictions of cancer mortality provide an estimate of the future burden of cancer and are fundamental to the process of planning of cancer control programmes and healthcare interventions. Projections become a valuable tool in evaluating the effectiveness of screening programmes which are directed to the reduction of cancer mortality [1] .
Estimates of current cancer mortality statistics, extrapolated from official data of a few years earlier, have long been available for the USA [2] [3] [4] and have been published for the years 2011 and 2012 for the European Union (EU) as a whole and for its six most populous countries [5] [6] , based on the World Health Organization (WHO) mortality database [http://www3.who.int/whosis/ menu.cfm].
In this report, we present projections of mortality rates of cancer in Poland in 2020 for 24 major cancers on the basis of the observed trends in mortality rates during [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] , and estimate the implication in terms of expected deaths using government population projections.
Materials and methods
The cancer mortality rates for Poland in years [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] were calculated using the National Cancer Registry data (number of cancer deaths) and the Statistical Office population data. World Standard Population was used to calculate the age-standardized rates. For this analysis the 10 th Revision of the International Classification of Diseases (1994) was used. The estimated annual percentage change in age-standardized mortality rates for 2001-2010 period and 95% confidence intervals were calculated using the Joinpoint Regression Program 4.0.4 (http://surveillance.cancer.gov/joinpoint/). The predicted numbers of cancer deaths and agestandardized rates for the most frequent cancer sites among men and women in 2020 were calculated on the basis of the historical mortality trends for Poland in years 2001-2010 and demographic prognosis created by the Central Statistical Office (http://demografia.stat.gov. pl/BazaDemografia/Prognoza.aspx) using the method of Dyba and Hakulinen. The underlying theoretical assumptions apply to these analyses: 1. Future mortality trends can be modeled by extrapolating historical trends. 2. The lengths of the data time-series permit the estimation of models that take account of age-sex group specific trends. 3. The numbers of cancer deaths in each age-sextime-period stratum are Poisson distributed. 4. Where historic trends in standardized mortality are decreasing, a log-linear model is appropriate to estimate the average rate, whereas a linear model is used for increasing or constant trends to avoid explosive growth.
Models were fitted to age-specific cancer mortality rates for the age groups 0-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84, 85 and over. Due to the small number of cancer deaths in the youngest age groups, the groups have been aggregated into one 0-44. For some of the cancers a particular division into age groups representing the characteristic of these cancers was applied. For testicular cancer, Hodgkin disease and non-Hodgkin lymphoma (NHL) the youngest age-groups have been aggregated into one 0-19 and the oldest into one 75+, while the remaining age groups were grouped into 5-year bins. For brain, central nervous system cancers (brain CNS) and leukaemias, the models were fitted to binned 5-years age groups from 0-4 to 85+. Non-melanoma skin cancers (NMSC) are omitted from estimates of trends as they rarely cause serious illness or death.
Simple Poisson linear or log-linear models offer a good fit to the data giving reasonably precise predictions. The linear model assumes that the mortality rate for each age-group changes by a fixed quantity each year (linear change), while the log-linear models assumes that it changes by a fixed percentage (exponential change). The model provides 95% confidence limits of the estimates based on the uncertainty in the model parameters, and 95% prediction intervals, which include an additional uncertainty term based on the Poisson uncertainty of the individual death numbers/ rate estimates. The 95% prediction intervals, which are given here, are a truer estimate of the uncertainty of the prediction. Estimates of the parameters for each of the models were calculated using the STATA 11.0 Statistical package for Windows [7] [8] [9] [10] .
The predicted values for 2020 were compared to the years 2006-2010 (the 2006-2010 period is used as a baseline because a five-year average gives the most stable estimate of current number of deaths). The percentage change in the number of deaths from 2006-2010 to 2020 was divided into two parts: one part due to the change in risk of cancer death, and another part due to the additional change connected with population size and age distribution [11] .
Results
The historical trends of cancer mortality are the basis for the future prognosis. Figures 1 and 2 show the changes in the age-standardized mortality rates for Poland for the commoner cancers between 2001 and 2010. There has been a mortality decrease for all cancers combined in men and women. Significant decrease of mortality was observed for stomach cancer and Hodgkin lymphoma for both sexes, for esophagus, larynx and lung cancer in men, and liver and gallbladder cancer in women. Decrease of mortality was also observed for breast, colorectal and cervical cancer in women, liver cancer and NHL in men and for kidney cancer and leukaemias for both sexes. A statistically significant increase of mortality has occurred for colorectal cancer and melanoma skin cancer in men, and for lung, pancreatic and endometrial cancer in women.
On the basis of the historical trends and the future prognosis we can predict the decrease in all cancer mortality and in the same time the increase in number of cancer deaths. During the last 40 years cancers have become one of the major health problems in Poland. When considering the overall prognosis for Poland in 2020, the number of all cancers deaths combined (excluding non-melanoma skin cancer) is predicted to increase for both sexes. The predicted number of cancer deaths in Poland in 2020 is 104 117 (58 147 for men and 45 970 for women). There will be 12.0% increase in number of cancer deaths in men and 13.9% increase in women. For both sexes all increase will be attributable to demographic changes. Despite the decreasing tendency connected with risk (-13.4% for men, -4.6% for women) there will be an overall increase in number of deaths because of the strong increasing tendency connected with demography (25.4% for men, 18.5% for women) ( Table 1 , 2).
The structure of cancer mortality in Polish males will not be signifi cantly altered. The contribution of lung and stomach cancer to mortality will decrease while the impact of colorectal, prostate, pancreatic and bladder cancer will increase (Figure 3) . The major predicted change in cancer mortality in Polish women will be dominated by lung cancer, which will be the most frequent cancer death in female population in 2020. Lung cancer contribution, as well as ovarian, pancreatic and brain cancer will increase in the upcoming future while the contribution from colorectal cancer and breast cancer will not change signifi cantly (Figure 4) . Tables 1 and 2 show the forecasted change in the number of cancer deaths in Poland and the break down of the change in mortality into the contribution from change in risk and additional change connected with population structure. For most cancers the effect of demography is between 16% and 32%. The strongest positive infl uence of demography will be observed for endometrial and brain cancer in women, multiple myeloma, bladder, colorectal and prostate cancer in men, and for melanoma skin cancer for both sexes, while the smallest positive effect will be characteristic of cervical cancer in women and testicular cancer in men. The only cancer for which there is a decreasing trend in number of deaths connected with changes in population is Hodgkin disease in men. For women there will be very small positive infl uence of demography for Hodgkin disease.
The most notable increase in number of cancer deaths due to both risk and demography will be observed for colorectal cancer, melanoma skin cancer, pancreatic cancer and multiple myeloma in men, for endometrial, lung and brain cancer in women, and for oral cavity and pharyngeal cancers in both sexes. While the increasing tendency for melanoma skin cancer in men will be caused by risk as well as demography infl uence, the predicted increase in number of deaths in women will be the effect of demography infl uence only. For some cancers (prostate, bladder, brain in men, and bladder, ovarian, melanoma and multiple myeloma in women) nearly the whole (or completely whole) increase in number of deaths will be related to the demography infl uence. The changes in risk will be the reason for predicted increase in number of testicular cancer deaths. For stomach, liver, thyroid and gallbladder cancer in women there will be an overall decrease in number of deaths because of the strong decreasing tendency connected with risk despite the increasing tendency connected with demography. For esophageal, stomach, liver and lung cancer in males the increasing tendency due to changes in population is compensated by the decreasing trend connected with risk so the predicted number of cancer deaths in 2020 is stable comparing to the period 2006-2010. For leukaemias and NHL the decrease tendency connected with risk is overcompensated by the positive effect of demography so the number of deaths caused by these cancer will increase. The predicted dramatic decrease in number of deaths from Hodgkin disease in males and females will be connected with risk.
Discussion
Future predictions depend on the multiple assumptions, but the basic one is that the various factors which affect the mortality of a particular cancer (risk factors, case fi nding procedures, diagnostic methods, cancer survival) vary approximately linearly with time for each of the age groups under consideration, and therefore the sum of their effects is also approximately linear. Consequently, the relative contribution of these factors to cancer mortality does not need to be known, and their aggregate future contribution to mortality can be modeled as a linear combination of their individual contributions. These predictions assume that current trends will remain unchanged in the future and makes no assumption about changes in the exposure to risk factors but relies entirely on the extrapolation of the recorded rates in the past. It should be emphasized that the predicted numbers of deaths are uncertain and the prediction holds true as long as there are no qualitative or major quantitative changes in any of the underlying factors (smoking habits, screening programs, diagnostic methods etc.). Projections do not take into account the impact of possible future changes in the incidence of cancer, or of dying from cancer, other than in a general way. A prediction made by extrapolation shows how large the mortality would be if the trend in the mortality could not be affected. They are, therefore, a useful basis for examining the possible scenarios resulting from the changes in policy with respect to prevention, screening or treatment. The fact that the prediction does not come true may indicate the success of cancer prevention and treatment. The improvement in prognosis for some cancers partly as a result of screening and partly because of better treatment may result in lower than predicted cancer mortality. Deaths trends are affected by changes in survival as well as changes in incidence [12] [13] [14] [15] [16] .
Most of the anticipated increase in number of cancer deaths will be caused by the growing number of older people in the population. Between 2006-2010 and 2020, the age-adjusted mortality rates from all cancers combined excluding non-melanoma skin cancers are predicted to fall by 13% in men and by 5% in women. But the increase in number of deaths is still predicted and will be connected with increasing number of older people. This can lead to confusion in the interpretation of the results where the decreasing trend of the rates is accompanied by the increase of number of deaths. The increase in number of older people directly corresponds to an increase in number of people who will get cancers, the diseases which are characteristic for older population.
The process of aging of the population is the biggest determinant of the level of cancer mortality in the short future. In Polish population all increase in number of deaths will be connected with demography and will be caused by changes in the population size and structure. The number of deaths is projected to increase for most types of cancer even for those with decreasing rates because of the increase in the size of the population and ageing. The World Health Organization report shows that the future cancer risk will be based mostly on the increasing trend of an ageing population [17] .
Most cancer deaths (75.8% in men and 76.1% in women) in Poland occur in the population 60 and older, so any changes in the size of this population will be an important factor for the future cancer mortality. All-cancer mortality in Poland is the highest in the European Union for both sexes. The predicted all-cancer mortality for 2013 in Poland will be 25% higher than the average rates for the European Union in men and 13% higher in women [18] .
Male all-cancer mortality rates for 2006-2010 were about 86% higher than in women and the predicted greater fall in men only marginally reduces the gap. Based on the predictions for 2020, male all-cancer mortality (which is predicted to fall by 13.4%) will be higher than in women by about 69%. The slower decrease in female all-cancer mortality rates (4.6%) is largely due to the differential trends between the two sexes in lung cancer mortality, which is decreasing in men and increasing in women. This mirrors the differential trends in smoking prevalence observed in the past between the two sexes [19] [20] .
The steady increase in lung cancer mortality for women in Poland is expected to continue. Breast cancer rates are expected to be lower than lung cancer rates and the difference will be bigger than for 2006-2010 (predictions for 2020: 20.0/100 000 for lung cancer, 13.5/100 000 for breast cancer) because of the opposite trends which are predicted for these cancer, increasing mortality trend for lung cancer and decreasing trend for breast cancer. The change in lung cancer deaths will be connected with a rapid increase of mortality due to lung The steady decline in stomach cancer mortality that started several decades ago is still continuing. This may reflect declines in the prevalence of Helicobacter pylori infection, the main identified risk factor for gastric cancer, but dietary habits, as well as the fall of smoking in men, may also have played a role [21] .
Mortality rate for colorectal cancer is predicted to decline by 8.8% in women and to increase by 10.3% in men. Despite the decreasing rate trend in women there will be the increase in number of deaths for both sexes because of the demographic changes. The number of deaths will increase by 10.1% in women and by 42% in men. The participation in the organized colorectal cancer screening program, which has been introduced relatively recently, may affect the mortality above a certain age.
The predicted increase in number of prostate cancer deaths (24%) will be much lower than the prognosis for prostate cancer cases (98% increase) [22] . There appears to be little correlation between the extent of the increase in incidence and the recent declines in mortality. It remains unclear to what extent the increasing trends in incidence rates indicate true risk and how much is due to detection of latent disease. The decreasing prostate cancer mortality rates may be attributable to improvements in treatment and to an effect of prostate specific antigen (PSA) testing [23] .
A general conclusion which can be drawn from these predictions is the necessity to prepare the health care system educationally, diagnostically, medically, economically and logistically to the growing number of cancer patients. Hospital care and long-term care will also need improvement in order to cater for the explosion in the number of cancer patients in the future.
